MIRA INFORM REPORT

 

 

Report No. :

340281

Report Date :

08.09.2015

 

IDENTIFICATION DETAILS

 

Name :

OTSUKA CHEMICAL (INDIA) PRIVATE LIMITED (w.e.f. 11.03.2010)

 

 

Formerly Known As :

OTSUKA CHEMICAL (INDIA) LIMITED (w.e.f. 14.11.2006)

 

OTSUKA CHEMICAL (INDIA) PRIVATE LIMITED

 

 

Registered Office :

861-862, Joshi Road, Karol Bagh, New Delhi – 110005

Tel. No.:

91-124-4597979

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

02.01.2006

 

 

Com. Reg. No.:

55-144368

 

 

Capital Investment / Paid-up Capital :

Rs.365.678 Million

 

 

CIN No.:

[Company Identification No.]

U24239DL2006PTC144368

 

 

IEC No.:

Not Available

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

DELO02697C

 

 

PAN No.:

[Permanent Account No.]

AAACO8042K

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of drug intermediates.

 

 

No. of Employees :

290 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (47)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having satisfactory track.

 

Overall financial position of the company seems to be decent.

 

Trade relations are fair. Business is active. Payment terms are reported as usually correct.

 

The company can be considered for business dealings at usual trade terms and conditions.

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2013.

 

 

INFORMATION PARTED BY (GENERAL DETAILS)

 

Name :

Mr. Sudhanshu

Designation :

Company Secretary

Contact No.:

91-124-4597979

Date :

07.09.2015

 

 

LOCATIONS

 

Registered Office :

861-862, Joshi Road, Karol Bagh, New Delhi – 110005, India

Tel. No.:

Not Available

Fax No.:

Not Available

E-Mail :

accounts@otsukaindia.com

Website :

www.otsukaindia.com

 

 

Corporate Office :

#416, JMD Pacific Square, Sector-15, Part-II, Near 32nd Mile Stone, Gurgaon – 122001, India

Tel. No.:

91-124-4597979

 

 

Factory :

SP-3, 10 and 11, RIICO Industrial Area, Village Keshwand, Rajkot, Tehsil-Kotputli, District-Jaipur, Rajasthan, India

 

 

DIRECTORS

 

AS ON 17.06.2014

 

Name :

Mr. Takae Yamada

Designation :

Managing Director

Address :

Apartment No. 84, 8th Floor, Block J DLF Park Place, Gurgaon - 122009, Haryana, India

Date of Birth/Age :

23.03.1966

Date of Appointment :

17.06.2014

DIN No.:

06898143

 

 

Name :

Mr. Mridul Dhanuka

Designation :

Director

Address :

Plot No. 95B, E-2 Lane, Eastern Avenue, Sainik Farms, New Delhi - 110062, India

Date of Birth/Age :

20.10.1980

Date of Appointment :

02.01.2006

DIN No.:

00199441

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U70101DL2005PTC135106

M D BUILDTECH PRIVATE LIMITED

Director

20/04/2005

20/04/2005

-

Active

NO

2

U24100DL1993PLC052285

DHANUKA LABORATORIES LIMITED

Director

06/10/2005

06/10/2005

-

Active

NO

3

U24239DL2006PTC144368

OTSUKA CHEMICAL (INDIA) Private Limited

Director

02/01/2006

02/01/2006

-

Active

NO

4

U74899DL1960PLC003276

NORTHERN MINERALS LIMITED

Whole-time director

15/03/2007

15/03/2007

-

Amalgamated

NO

5

L34300DL1985PLC021785

HINDON MERCANTILE LIMITED

Director

07/09/2010

16/12/2009

25/03/2011

Amalgamated

NO

6

L65921DL1984PLC018746

EXCLUSIVE LEASING AND FINANCE LIMITED

Director

10/09/2010

17/12/2009

23/05/2011

Amalgamated

NO

7

U72200DL2006PTC147749

DHANUKA INFOTECH PRIVATE LIMITED

Director

30/09/2010

04/09/2010

-

Active

NO

8

L24219DL1985PLC020126

DHANUKA AGRITECH LIMITED

Whole-time director

29/07/2011

23/05/2011

-

Active

NO

 

 

Name :

Mr. Manish Dhanuka

Designation :

Director

Address :

Cottage No. 4, 31 B, Rajpur Road, Civil Lines, Delhi - 110054, India

Date of Birth/Age :

28.09.1967

Date of Appointment :

02.01.2006

DIN No.:

00238798

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U74899DL1990PTC040509

DUKE IMPEX PRIVATE LIMITED

Director

15/06/1990

15/06/1990

-

Amalgamated

NO

2

U24100DL1993PLC052285

DHANUKA LABORATORIES LIMITED

Managing director

01/03/2009

24/02/1993

-

Active

NO

3

U24239DL2006PTC144368

OTSUKA CHEMICAL (INDIA) Private Limited

Director

02/01/2006

02/01/2006

-

Active

NO

4

U74899DL1984PTC029568

COSMO COMPONENTS PRIVATE LIMITED

Director

13/02/2007

13/02/2007

-

Amalgamated

NO

5

U51101DL2014PTC263829

A.M. BROS. FINTRADE PRIVATE LIMITED

Director

22/01/2014

22/01/2014

-

Active

NO

 

 

Name :

Mr. Arun Malhotra

Designation :

Director

Address :

43 Deshbandhu Apartments, Kalkaji, New Delhi - 110019, India

Date of Birth/Age :

14.06.1960

Date of Appointment :

26.07.2010

DIN No.:

03147644

 

 

Name :

Mr. Kozo Yoshida

Designation :

Director

Address :

707, Nihonbashi, Hama Cho 1-9.4, Chuo-Ku, Tokyo, Na, Japan

Date of Birth/Age :

13.09.1964

Date of Appointment :

26.07.2011

DIN No.:

03585039

 

 

Name :

Mr. Masahiro Ito

Designation :

Director

Address :

F-2/502, Uniworld City, Sector-30, Gurgaon - 122001, Haryana, India

Date of Birth/Age :

18.02.1967

Date of Appointment :

17.06.2013

DIN No.:

06609311

 

 

Name :

Mr. Ryo Kikuchi

Designation :

Additional Director

Address :

Flat No.21, X Block, Regency Park II, DLF City Phase IV, Gurgaon - 122001, Haryana, India

Date of Birth/Age :

11.12.1957

Date of Appointment :

17.06.2014

DIN No.:

02780746

Other Directorship:

S.

No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239DL2006PTC144368

OTSUKA CHEMICAL (INDIA) Private Limited

Additional director

17/06/2014

30/09/2009

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Kapil

Designation :

Assistant Manager  Purchase

 

 

Name :

Mr. Sudhanshu Shekhar Thakur

Designation :

Company Secretary

Address :

Gali No.7. Near Choti Hanuman Mandir, Patel Nagar, Gurgaon - 122001, Haryana, India

Date of Birth/Age :

26.11.1975

Date of Appointment :

02.06.2008

PAN No.:

AFTPT3667E

 

 

MAJOR SHAREHOLDERS

 

AS ON 17.06.2014

 

Names of Shareholders

 

No. of Shares

% of Holding

Manish Dhanuka

50000

0.14

Mridul  Dhanuka

50000

0.14

Dhanuka Laboratories Limited, India

1927248

5.27

Otsuka Chemical Company Limited, Japan

34540561

94.46

Total

36567809

100.00

 

 

Equity Share Break up (Percentage of Total Equity)

 

AS ON 17.06.2014

 

Category

Percentage

Foreign holdings [Foreign institutional investor(s), Foreign companie(s) Foreign financial institution(s), Non-resident Indian(s) or Overseas Corporate bodies or Others]

94.46

Bodies corporate

5.27

Directors or relatives of Directors

0.27

Total

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of drug intermediates.

 

 

Products :

Drug Intermediates

 

 

Brand Names :

Not Divulged

 

 

Agencies Held :

Not Divulged

 

 

Exports :

 

Products :

Finished Goods

Countries :

·         China

·         Japan

 

 

Imports :

 

Products :

Raw Material

Countries :

·         China

 

 

Terms :

 

Selling :

Cash, Cheque, Credit

 

 

Purchasing :

Cash, Cheque, Credit

 

 

PRODUCTION STATUS – NOT AVAILABLE

 

 

GENERAL INFORMATION

 

Suppliers :

Company Name :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark :

Not Divulged

 

 

Customers :

Company Name :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark :

Not Divulged

 

 

No. of Employees :

290 (Approximately)

 

 

Bankers :

Banker Name :

Bank of Tokyo

Branch :

Delhi, India

Person Name (With Designation) :

Not Divulged

Contact Number :

Not Divulged

Name of Account Holder :

Not Divulged

Account Number :

Not Divulged

Account Since (Date/Year of Account Opening) :

Not Divulged

Average Balance Maintained :

Not Divulged

Credit Facilities Enjoyed (CC/OD/Term Loan) :

Not Divulged

Account Operation :

Not Divulged

Remark :

Not Divulged

 

 

Facilities :

SECURED LOANS

31.03.2014

Rs. In Million

31.03.2013

Rs. In Million

Short Term Borrowings

 

 

Working capital loans from banks

[Secured against letter of guarantee of Otsuka Chemical Company Limited, Japan]

448.424

403.441

 

 

 

Total

448.424

403.441

 

 

Auditors :

 

Name :

Dinesh Mehta and Company

Chartered Accountants

Address :

21 Dayanand Marg, Daryaganj, New Delhi – 110002, India

PAN No.:

AAAFD3623P

 

 

Memberships :

Not Divulged

 

 

Collaborators :

Not Divulged

 

 

Holding company :

·         Otsuka Chemical Company Limited, Japan

 

 

Fellow Subsidiary Company :

·         Otsuka Foods Company Limited, Japan

·         Hebron S.A (Spain), Spain

·         Otsuka MGC Chemical Company Limited, Japan

·         Shanghai Otsuka Foods Company Limited, Japan

·         Otsuka Chilled Foods Company Limited, Japan

·         P.T. Lautan Otsuka Chemical, Japan

·         Zhangijagang Otsuka Chemical Company Limited, Japan

·         Aperican Peptide Company, Inc, Japan

·         Korea Otsuka Chemical Limited, Korea Republic of

·         Chongqing Otsuka Hauyi Chemical Company Limited, Korea Republic of

·         Otsuka Chemical do Brasil, Brazil

·         ILS Company Limited, Japan

·         ILS (Shanghai) Company Limited, Japan

·         Organ Technologies Inc., Japan

 

 

Enterprises which are owned, or have significant influence of or are partners with Key management personnel and their relatives :

·         Dhanuka Laboratories Limited, India

 

 

CAPITAL STRUCTURE

 

AS ON 17.06.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

38500000

Equity Shares

Rs.10/- each

Rs.385.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

36567809

Equity Shares

Rs.10/- each

Rs.365.678 Million

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

365.678

365.678

324.198

(b) Reserves & Surplus

1335.375

1194.676

898.561

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

0.000

228.143

Total Shareholders’ Funds (1) + (2)

1701.053

1560.354

1450.902

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

0.000

0.000

187.290

(b) Deferred tax liabilities (Net)

0.000

0.000

0.000

(c) Other long term liabilities

0.000

0.000

0.000

(d) long-term provisions

5.063

4.153

3.576

Total Non-current Liabilities (3)

5.063

4.153

190.866

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

448.424

403.441

339.279

(b) Trade payables

321.697

259.762

234.912

(c) Other current liabilities

39.458

32.396

230.428

(d) Short-term provisions

11.360

13.384

7.688

Total Current Liabilities (4)

820.939

708.983

812.307

 

 

 

 

TOTAL

2527.055

2273.490

2454.075

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

1398.504

1089.706

1129.304

(ii) Intangible Assets

0.000

0.000

0.000

(iii) Capital work-in-progress

0.000

54.765

60.223

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

35.712

115.023

19.897

(e) Other Non-current assets

4.229

30.788

0.683

Total Non-Current Assets

1438.445

1290.282

1210.107

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

351.356

306.181

260.885

(c) Trade receivables

596.269

494.395

528.495

(d) Cash and cash equivalents

25.361

103.922

322.784

(e) Short-term loans and advances

115.624

78.710

131.804

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

1088.610

983.208

1243.968

 

 

 

 

TOTAL

2527.055

2273.490

2454.075

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

 

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

 

Income

2328.563

1866.523

1589.166

 

 

Other Income

NA

NA

NA

 

 

TOTAL                                              (A)

NA

NA

NA

 

 

 

 

 

Less

TOTAL EXPENSES                                             (B)

NA

NA

NA

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B)     (C)

322.017

280.206

98.106

 

 

 

 

 

Less

FINANCIAL EXPENSES                                    (D)

9.702

11.873

17.215

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D)                                (E)

312.315

268.333

80.891

 

 

 

 

 

Less

DEPRECIATION/ AMORTISATION                     (F)

171.617

158.880

163.227

 

 

 

 

 

 

PROFIT/(LOSS) BEFORE TAX (E-F)                  (G)     

140.698

109.453

(82.336)

 

 

 

 

 

Less

TAX                                                                  (H)

0.000

0.000

0.000

 

 

 

 

 

 

PROFIT/(LOSS) AFTER TAX (G-H)                    (I)

140.698

109.453

(82.336)

 

 

 

 

 

 

Earnings Per Share (Rs.)

3.85

--

--

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

0.000

0.000

187.290

Cash generated from operations

NA

NA

NA

Net cash flow from (used in) operations

291.616

202.289

(75.720)

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

PAT / Sales

(%)

6.04

5.86

(5.18)

 

 

 

 

 

Operating Profit Margin

(PBDIT/Sales)

(%)

13.83

15.01

6.17

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets)

(%)

5.57

4.93

(3.44)

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.08

0.07

(0.06)

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

0.26

0.26

0.49

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.33

1.39

1.53

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Share Capital

324.198

365.678

365.678

Reserves & Surplus

898.561

1194.676

1335.375

Share Application money pending allotment

228.143

0.000

0.000

Net worth

1450.902

1560.354

1701.053

 

 

 

 

long-term borrowings

187.290

0.000

0.000

Short term borrowings

339.279

403.441

448.424

Current Maturities of Long term debt

187.290

0.000

0.000

Total borrowings

713.859

403.441

448.424

Debt/Equity ratio

0.492

0.259

0.264

 

 

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Sales

1589.166

1866.523

2328.563

 

 

17.453

24.754

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

Rs. In Million

Rs. In Million

Rs. In Million

Sales

1589.166

1866.523

2328.563

Profit

(82.336)

109.453

140.698

 

(5.18%)

5.86%

6.04%

 

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

No

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

No

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last three years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

 

OVERALL REVIEW

 

Overall this FY has been a good year for the company. We register a 24.75% growth in sales volume and 30.0% growth in production capacity. Our profit increased by 28.61%. We also recorded highest production of GCLE (748.2 MT). During this period they also diversified into forward integration of GCLE to produce another vital intermediate.

 

 

HIGHLIGHTS OF FY 2013 - 14

 

During the period, subject has successfully implemented many productivity increasing and cost reducing measures. As a result of these efforts and measures taken during this FY, subject is able to increase our production capacity and reduce the cost of production of GCLE at the right time, enabling us to survive in today's stiffest competition offered by Indian and Chinese competitors. This year they are able to increase their GCLE production capacity by 30 % as compared to last financial year and various other steps are also taken to improve the productivity and to minimize the cost, which may get reflected in the results of coming years. They are gearing ourselves to face the future challenge and to overcome the resistance offered by their competitors and they are confident that they will emerge out as victorious.

 

During this financial year, subject has also diversified into forward integration of GCLE, by creating a new facility in the existing premises with an investment of about Rs 450.000 Million to produce a new intermediate product GCTA. This intermediate will be supplied to our patent company, OCC, japan to produce an advance drug intermediate for Originator in Japan. The new facility is, not only utilized to produce GCTA, but is also used for the production of GCLE when GCTA is not produced. This additional capacity of GCLE produced in GCTA facility has increased their market share of GCLE not only in India but also due to the availability of extra material they have started exporting GCLE to China.

 

 

FINANCIAL REVIEW

 

This Financial Year subject has recorded a sales turnover of Rs.2328.563 Million and registered a growth of 24.75% as compared to previous Financial Year 2012-2013. Subject has registered Rs.140.698 Million profit before tax compared to profit of Rs.109.453 Million i.e. greater than 28.61% during the same period last year.

 

 

NO CHARGES EXIST FOR COMPANY.

 

 

FIXED ASSETS:

 

·         Land

·         Building

·         Plant and Machinery

·         Furniture and Fixture

·         Office Equipment

·         Computer

·         Vehicles

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

 

Unit

Indian Rupees

US Dollar

1

Rs.66.74

UK Pound

1

Rs.101.36

Euro

1

Rs.74.27

 

 

INFORMATION DETAILS

 

Information Gathered by :

SVA

 

 

Analysis Done by :

RAS

 

 

Report Prepared by :

NKT

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

6

--PROFITABILITY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

6

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

 

 

 

TOTAL

 

47

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

NB

NEW BUSINESS

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.